The award-winning P3 Program® mobilizes the expertise of pharmacists in its groundbreaking patient-centered approach to improving health and lowering costs of care.
The P3 Program is a partnership among the University of Maryland School of Pharmacy, the Maryland Pharmacists Association, the Maryland General Assembly, and the Maryland Department of Health and Mental Hygiene. It positions pharmacists to play a more dynamic role on the frontline of health care.
By joining this network, pharmacists have a unique opportunity to empower patients to take control of their health, provide critical support around common prevention measures, and serve as a central point of contact for physicians and other relevant providers. Participating pharmacists will be trained to use evidence-based practices and motivational strategies to serve as a pharmacist coach who works individually with patients to meet life-enhancing health goals and achieve better outcomes through medication adherence.
The clinical guidelines below outline the standards of care to which pharmacists in the P3 Program must adhere when counseling patients.
- 2018 ACC/AHA Guideline on the Management of Blood Cholesterol
Key Perspectives for Managing Blood Cholesterol
The following are key perspectives from the 2018 Multisociety Guideline on the Management of Blood Cholesterol, based on the Top Ten Take Home Messages selected by the Writing Committee. Learn more.
Please note the following for Diabetes Patients:
In patients 40 to 75 years of age with diabetes mellitus and an LDL-C level of ≥70 mg/dl, start moderate-intensity statins without calculating 10-year ASCVD risk. In patients with diabetes mellitus at higher risk, especially those with multiple risk factors or those 50 to 75 years of age, it is reasonable to use a high-intensity statin to reduce the LDL-C level by ≥50%.
- ADA 2018 - Standards of Medical Care in Diabetes: Issued by the American Diabetes Association, these standards of care are intended to provide clinicians, patients, researchers, payers, and other interested individuals with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care. View the corresponding PowerPoint presentation that highlights the updated guidelines here.
- JNC 8 - Evidence-Based Guidelines for the Management of High Blood Pressure in Adults: Published by the National Heart, Lung, and Blood Institute, this report provides an evidence-based approach to the prevention and management of hypertension.
- ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: Published by the American College of Cardiology and the American Heart Association, this guideline offers evidence-based advice about reducing and managing cardiovascular risk in adults.
- AACE/ACE Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan: Published by the American Association of Clinical Endocrinologists and American College of Endocrinology, these guidelines offer evidence-based advice about developing a care plan for patients with diabetes.
How to Get Involved:
Please explore the resources below for more information about how to get involved with the program.
- Program Overview: This document provides a brief description of the P3 Program and explains the benefits to pharmacists who participate.
- Provider Requirements: This document outlines the requirements a pharmacist must meet before joining the P3 Program.
- Provider Information Sheet: Please complete this form and submit it to firstname.lastname@example.org if you are interested in joining the P3 Program.
The additional resources below have been provided for informational use only.
- iForumRx: iForumRx is an interactive web-based community designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high quality, practice-changing evidence.
- Improving Patient and Health System Outcomes through Advanced Pharmacy Practice: This report to the US Surgeon General from 2011 provides health leadership with evidence-based discussion about improving patient and health system outcomes through an additional paradigm of health care delivery for expanded implementation in the United States.
- UMB IT Policies: The Center for information Technology Services (CITS) at the University of Maryland, Baltimore (UMB) maintains policies with regard to the use and security of its information technology resources. All users of these resources are expected to be familiar with these policies and the consequences of violation. These policies have been developed to protect the confidentiality, integrity, and availability of University data.